Corporate Profile

Intrexon Corporation, founded in 1998, is a leader in synthetic biology focused on collaborating with companies in Health, Food, Energy, Environment and Consumer sectors to create biologically based products that improve quality of life and the health of the planet. At present rates of global industrialization and population growth, food and energy supplies and environmental and healthcare resources are becoming scarcer. We believe Intrexon’s leading Better DNA® approach to synthetic biology has the potential to provide new, more effective and sustainable solutions to address these challenges. 

With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells. Working with key collaborators, Intrexon seeks to develop high value applications that can bring better medicines to more people, alleviate shortages of essential nutrients, develop renewable fuels and other resources, and protect the environment.

AquaBounty Distribution
Recent Press Releases
Nov 27, 2017

Intrexon Corporation (NYSE: XON), a leader in the engineering and industrialization of biology, today announced key executive promotions: Lt. Gen. (Ret.) Thomas Bostick, Ph.D., has been named...

Nov 10, 2017

Intrexon Corporation (NYSE: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today announced that Randal J. Kirk,...

Nov 9, 2017

Intrexon Corporation (NYSE: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today announced its third quarter financial...

Nov 1, 2017

Intrexon Corporation (NYSE: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today announced it will release third...

More >>

Investor Contact

Christopher Basta
Vice President, Investor Relations
Work: 561-410-7052
Cell: 516-307-6292
E-mail: investors@intrexon.com


print email